Biosimilars are a welcome addition to medical therapies available for a wide array of patients and diseases, though understanding the issues around the biosimilar approval process can be difficult. This short video aims to provide doctors and patients with education on these the issues, including why biosimilars can never be precisely duplicated, how indication extrapolation works and more on the rigorous, but abbreviated path to approval.
Doctors and patients can have a degree of confidence in the safety of biosimilars, yet will have much to learn as their use increases in the clinical practice. When it comes to biosimilars, patients depend on doctors to make knowledgeable choices. BPC is committed to providing educational materials on biosimilars to ensure their safe use.